Skip to main content

Inovio Pharmaceuticals, Inc.

INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001055726

No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.

13F holders, Q1 2021

Institutional positions in Inovio Pharmaceuticals, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
219
No complete 13F data for Q4 2020
Shares held
74.8M
No complete 13F data for Q4 2020
Total value
$693.7M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting INO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 219 institutions
Q1 2021: 219 institutionsQ2 2021: 211 institutionsQ3 2021: 213 institutionsQ4 2021: 209 institutionsQ1 2022: 201 institutionsQ2 2022: 185 institutionsQ3 2022: 183 institutionsQ4 2022: 186 institutionsQ1 2023: 177 institutionsQ2 2023: 135 institutionsQ3 2023: 127 institutionsQ4 2023: 116 institutionsQ1 2024: 89 institutionsQ2 2024: 96 institutionsQ3 2024: 98 institutionsQ4 2024: 105 institutionsQ1 2025: 108 institutionsQ2 2025: 103 institutionsQ3 2025: 99 institutionsQ4 2025: 101 institutionsQ1 2026: 99 institutionsQ2 2026: 101 institutions
Value heldQ1 2021: $693.7M
Q1 2021: $693.7MQ2 2021: $683.1MQ3 2021: $554.9MQ4 2021: $428.9MQ1 2022: $330.4MQ2 2022: $196.2MQ3 2022: $200.0MQ4 2022: $198.5MQ1 2023: $99.8MQ2 2023: $32.1MQ3 2023: $21.6MQ4 2023: $25.7MQ1 2024: $56.4MQ2 2024: $65.1MQ3 2024: $49.5MQ4 2024: $24.4MQ1 2025: $22.2MQ2 2025: $20.7MQ3 2025: $48.4MQ4 2025: $57.5MQ1 2026: $54.6MQ2 2026: $36.1M
Institutions holding INO and their total value by quarter
QuarterHoldersValue
Q2 2026101$36.1M
Q1 202699$54.6M
Q4 2025101$57.5M
Q3 202599$48.4M
Q2 2025103$20.7M
Q1 2025108$22.2M
Q4 2024105$24.4M
Q3 202498$49.5M
Q2 202496$65.1M
Q1 202489$56.4M
Q4 2023116$25.7M
Q3 2023127$21.6M
Q2 2023135$32.1M
Q1 2023177$99.8M
Q4 2022186$198.5M
Q3 2022183$200.0M
Q2 2022185$196.2M
Q1 2022201$330.4M
Q4 2021209$428.9M
Q3 2021213$554.9M
Q2 2021211$683.1M
Q1 2021219$693.7M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Inovio Pharmaceuticals, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding INO in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Goodwin Investment Advisory250$2.00K0.00%––
FMR LLC125$1.00K0.00%––
North Star Investment Management Corp.94$1.00K0.00%––
Riggs Asset Managment Co. Inc.125$1.00K0.00%––
Patriot Financial Group Insurance Agency, LLC73$1.00K0.00%––
BDO Wealth Advisors, LLC100$1.00K0.00%––
Prestige Wealth Management Group LLC110$1.00K0.00%––
Concord Wealth Partners104$1.00K0.00%––
Atlas Private Wealth Advisors150$1.00K0.00%––
State of Wyoming123$1.00K0.00%––
Financial Perspectives, Inc4,640$5000.02%––
Ancora Advisors, LLC40$00.00%––
Simplex Trading, LLC5,731$00.00%––
Highlander Capital Management, LLC50$00.00%––
Hudock, Inc.9$00.00%––
Bogart Wealth, LLC50$00.00%––
Hoover Financial Advisors, Inc.10$00.00%––
Leelyn Smith, LLC8$00.00%––
Total Clarity Wealth Management, Inc.50$00.00%––